Successful treatment with lenalidomide plus chidamide combination therapy in 3 heavily treated patients with non-Hodgkin lymphoma: Three cases report

RATIONALE: The prognosis of patients with aggressive relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL) remains poor. Both immunomodulatory drugs and histone deacetylase inhibitors have demonstrated activity against R/R NHL; yet, the combination of these 2 targeted therapies has rarely been exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Shaoxuan, Zou, Dongmei, Zhou, Daobin, Zhang, Yan, Wang, Wei, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581128/
https://www.ncbi.nlm.nih.gov/pubmed/33120793
http://dx.doi.org/10.1097/MD.0000000000022788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581128/
https://www.ncbi.nlm.nih.gov/pubmed/33120793
http://dx.doi.org/10.1097/MD.0000000000022788

Ejemplares similares